Bank Of America Corp Benitec Biopharma Inc. Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
SELL
$2.62 - $3.77 $238 - $343
-91 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$3.49 - $4.26 $317 - $387
91 New
91 $0

Others Institutions Holding BNTC

# of Institutions
2
Shares Held
797K
Call Options Held
0
Put Options Held
0
View Full List

About Benitec Biopharma Inc.

BNTC Quotes by TradingView
  • Ticker BNTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,809,500
  • Market Cap $299M
  • Description
  • Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...
More about BNTC
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email